Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice"

Michelle H. Larsen; William R. Jacobs; Steven A. Porcelli; John Kim; Uma Devi K. Ranganathan; Glenn J. Fennelly

doi:10.1016/j.vaccine.2010.03.025

Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice"

Michelle H. Larsen, William R. Jacobs, Steven A. Porcelli, John Kim, Uma Devi K. Ranganathan, Glenn J. Fennelly

Microbiology & Immunology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	3633-3634
Number of pages	2
Journal	Vaccine
Volume	28
Issue number	21
DOIs	https://doi.org/10.1016/j.vaccine.2010.03.025
State	Published - May 7 2010

ASJC Scopus subject areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2010.03.025

Cite this

Larsen, M. H., Jacobs, W. R., Porcelli, S. A., Kim, J., Ranganathan, U. D. K., & Fennelly, G. J. (2010). Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice". Vaccine, 28(21), 3633-3634. https://doi.org/10.1016/j.vaccine.2010.03.025

Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice". / Larsen, Michelle H.; Jacobs, William R.; Porcelli, Steven A. et al.
In: Vaccine, Vol. 28, No. 21, 07.05.2010, p. 3633-3634.

Research output: Contribution to journal › Letter › peer-review

Larsen, MH , Jacobs, WR , Porcelli, SA, Kim, J, Ranganathan, UDK & Fennelly, GJ 2010, 'Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice"', Vaccine, vol. 28, no. 21, pp. 3633-3634. https://doi.org/10.1016/j.vaccine.2010.03.025

Larsen MH , Jacobs WR , Porcelli SA, Kim J, Ranganathan UDK, Fennelly GJ. Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice". Vaccine. 2010 May 7;28(21):3633-3634. doi: 10.1016/j.vaccine.2010.03.025

Larsen, Michelle H. ; Jacobs, William R. ; Porcelli, Steven A. et al. / Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV : Response to Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice". In: Vaccine. 2010 ; Vol. 28, No. 21. pp. 3633-3634.

@article{758dfd75506345e3852f0d47689f6a8f,

title = "Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. {"}Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice{"}",

author = "Larsen, {Michelle H.} and Jacobs, {William R.} and Porcelli, {Steven A.} and John Kim and Ranganathan, {Uma Devi K.} and Fennelly, {Glenn J.}",

year = "2010",

month = may,

day = "7",

doi = "10.1016/j.vaccine.2010.03.025",

language = "English (US)",

volume = "28",

pages = "3633--3634",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "21",

}

TY - JOUR

T1 - Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV

T2 - Response to Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice"

AU - Larsen, Michelle H.

AU - Jacobs, William R.

AU - Porcelli, Steven A.

AU - Kim, John

AU - Ranganathan, Uma Devi K.

AU - Fennelly, Glenn J.

PY - 2010/5/7

Y1 - 2010/5/7

UR - http://www.scopus.com/inward/record.url?scp=77953135716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953135716&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2010.03.025

DO - 10.1016/j.vaccine.2010.03.025

M3 - Letter

C2 - 20347058

AN - SCOPUS:77953135716

SN - 0264-410X

VL - 28

SP - 3633

EP - 3634

JO - Vaccine

JF - Vaccine

IS - 21

ER -

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this